<<

The Nose Knows - ENT for the Family Physician Jennifer Caudle, DO ACOFP FULL DISCLOSURE FOR CME ACTIVITIES

Please check where applicable and sign below. Provide additional pages as necessary. Name of CME Activity: ACOFP Intensive Update and Board Review in Osteopathic Family Medicine Dates and Location of CME Activity: August 21-24, 2014, InterContinental Chicago O'Hare, Rosemont, IL

Topic(s): The Nose Knows - ENT for the Family Physician Saturday, 8/23/14 1:45-2:15pm Name of Faculty/Moderator: Jennifer Caudle, DO

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITHIN 12 MONTHS OF DATE OF THIS FORM A. Neither I nor any member of my immediate family has a financial relationship or interest with any proprietary entity producing x health care goods or services. B. I have, or an immediate family member has, a financial relationship or interest with a proprietary entity producing health care goods or services. Please check the relationship(s) that applies. Research Grants Stock/Bond Holdings (excluding mutual funds) Speakers’ Bureaus* Employment Ownership Partnership Consultant for Fee Others, please list:

Please indicate the name(s) of the organization(s) with which you have a financial relationship or interest, and the specific clinical area(s) that correspond to the relationship(s). If more than four relationships, please list on separate piece of paper: Organization With Which Relationship Exists Clinical Area Involved 1. 1. 2. 2. 3. 3. 4. 4.

*If you checked “Speakers’ Bureaus” in item B, please continue: • Did you participate in company-provided speaker training related to your proposed topic? Yes: No: • Did you travel to participate in this training? Yes: No: • Did the company provide you with slides of the presentation in which you were trained as a speaker? Yes: No: • Did the company pay the travel/lodging/other expenses? Yes: No: • Did you receive an honorarium or consulting fee for participating in this training? Yes: No: • Have you received any other type of compensation from the company? Please specify: Yes: No: • When serving as faculty for ACOFP, will you use slides provided by a proprietary entity for your presentation and/or lecture handout materials? Yes: No: • Will your topic involve information or data obtained from commercial speaker training? Yes: No:

DISCLOSURE OF UNLABELED/INVESTIGATIONAL USES OF PRODUCTS __x__A. The content of my material(s)/presentation(s) in this CME activity will not include discussion of unapproved or investigational uses of products or devices. ____B. The content of my material(s)/presentation in this CME activity will include discussion of unapproved or investigational uses of products or devices as indicated below:

I have read the ACOFP policy on full disclosure. If I have indicated a financial relationship or interest, I understand that this information will be reviewed to determine whether a conflict of interest may exist, and I may be asked to provide additional information. I understand that failure or refusal to disclose, false disclosure, or inability to resolve conflicts will require the ACOFP to identify a replacement.

Signature: Jennifer Caudle, DO Date: 6/1/14 Jennifer Caudle, DO

Please fax this form to ACOFP at 866-328-1835 or email to [email protected] as soon as possible Deadline: Saturday, May 31, 2014

8/6/2014

EAR NOSE & THROAT DR. JENNIFER CAUDLE

ASST PROFESSOR, DEPT OF FAMILY MEDICINE 3RD YEAR FM CLERKSHIP DIRECTOR ROWAN UNIVERSITY SCHOOL OF OSTEOPATHIC MEDICINE

ACOFP Family Medicine Board Review August 23, 2014

Otolaryngology Topics

Dizziness Loss Rhinosinusitis Externa Hoarseness & SCC of Larynx

Dizziness

Dizziness: A Diagnostic Approach ROBERT E. POST, MD, LORI M. DICKERSON, PharmD, Medical University of South Carolina, Charleston, South Carolina. Am Fam Physician. 2010 Aug 15;82(4):361-368.

1 8/6/2014

Dizziness

 Disturbance of the sensory modalities which allow of body's motion and position in space  vision  vestibular input  joint position  touch  hearing  CC in ~ 3% of primary care visits for patients 25 years and older  The final cause of dizziness is not identified in up to one in five patients.

Categories of Dizziness

1. - Central Origin (, , etc) - Peripheral Origin A. Benign paroxysmal positional vertigo (BPPV) B. Meniere disease C. Vestibular D. E. Migrainous vertigo / vestibular migraine

2. Presyncope

3. Lightheadedness

4. Disequilibrium

Symptoms

 Vertigo  Perceived of motion, spinning sensation (45 - 54%)

 Pre-syncope  Feeling of losing consciousness or blacking out (~14%)

 Lightheadedness  Vague symptoms, feeling disconnected with the environment (~10%)

 Disequilibrium  Feeling off-balance or wobbly (~16%)

2 8/6/2014

1. Vertigo

Perceived sense of motion, possibly spinning sensation

1. Central Origin 2. Peripheral Origin (MCC of vertigo)

Peripheral Vestibular Disorders

 Peripheral vestibular disorders are the MCC of Vertigo:

A. Benign paroxysmal positional vertigo (BPPV) B. Meniere disease C. Vestibular neuritis D. Labyrinthitis E. Migrainous vertigo / Vestibular migraine

Peripheral Vestibular Causes of Vertigo A. Benign Positional Paroxysmal Vertigo

 MCC of peripheral vestibular vertigo

 Pathophysiology  Crystalline debris forms/moves in which causes labyrinthine irritation vertigo & . Head movement often cause symptoms.

3 8/6/2014

Benign Positional Paroxysmal Vertigo

 Symptoms/Diagnosis

 Brief episodes of vertigo (2-10 seconds)  Nystagmus and vertigo often caused by turning the head  Dix-Hallpike Maneuver  Reproduces vertigo, resulting in nystagmus  Diagnostic if (+) but does not rule it out if (-). Sensitivity = 50–88% for BPPV.  Has a PPV of 83% and a negative predictive value of 52% for the diagnosis of BPPV

BPPV Diagnosis: Dix-Hallpike Maneuver

The patient is seated, the physician (A) turns the patient's head 45 degrees to one side, then (B) rapidly lays the patient into a supine position with the head hanging about 20 degrees over the end of the table, observing the patient's eyes for approximately 30 seconds. The maneuver is repeated for the opposite side. Nystagmus is diagnostic of vestibular debris in the facing down, closest to the exam table. A video demonstration of this maneuver is available at http://www.youtube.com/watch?v=vRpwf2mI3SU. Dizziness: A Diagnostic Approach ROBERT E. POST, MD, LORI M. DICKERSON, PharmD, Medical University of South Carolina, Charleston, South Carolina. Am Fam Physician. 2010 Aug 15;82(4):361-368.

Benign Positional Paroxysmal Vertigo

 Treatment

 Epley, modified Epley and Semont maneuvers (slide at end of lecture)  Canolith repositioning maneuvers. Goal is to reposition the crystals into the vestibule.  80% success rate in relieving symptoms  Often resolves with time whether or not exercises are done  Vestibular Rehabilitation  Should not be routinely treated w vestibular suppressants, i.e or benzodiazepines  Potential side effects including drowsiness, cognitive side effects, etc., & may interfere with CNS compensation for vestibular injury

4 8/6/2014

Treatment: Epley maneuver

Dizziness: A Diagnostic Approach ROBERT E. POST, MD, LORI M. DICKERSON, PharmD, Medical University of South Carolina, Charleston, South Carolina. Am Fam Physician. 2010 Aug 15;82(4):361-368.

Peripheral Vestibular Causes of Vertigo B. Meniere's disease

 Pathophysiology (‘endolymphatic hydrops’)  Buildup of fluid in endolymphatic system, caused by excess fluid production or decreased fluid resorption. This results in dilation of the endolymphatic system.

 Symptoms/Diagnosis  Recurrent episodes of vertigo that last hours (not mins or days)  Sensorineural low-frequency  Aural fullness in affected ear

Meniere's disease

 Treatment  No cure, aim for symptom reduction  Salt restriction  Diuretic therapy, HCTZ  If acutely sensitive to ETOH, Caffeine or both, avoid these  Anti-emetics  Benzodiazepines  Surgical decompression of endolymphatic system for refractory patients  EPLEY MANEUVER & STEROIDS= NOT HELPFUL

5 8/6/2014

Peripheral Vestibular Causes of Vertigo C. Vestibular Neuronitis

 Pathophysiology  of the vestibular nerve with total sparing of the cochlear area.

 Symptoms/Diagnosis  Often associated with viral infection  Severe prolonged vertigo (days) with ataxia, and .  NO hearing loss, no tinnitus, no aural  Symptoms often initially severe and gradually decrease over 1-2 weeks.  Reduced/absent caloric response, at least initially

Vestibular Neuronitis

 Treatment  Rest  Reassurance and anti-emetics  Vestibular suppressants (diazepam, meclizine)  Vestibular Rehab, (possibly for refractory cases)

Peripheral Vestibular Causes of Vertigo D. Labyrinthitis

 Pathophysiology  Inflammation of the labyrinthine organs.

 Symptoms  Often associated w/ or URI (viral or bacterial infection).  Severe vertigo, can last > days  Tinnitus  Sensorineural hearing loss

6 8/6/2014

Labyrinthitis

 Diagnostic Clue  Labyrinthitis and vestibular neuronitis can occur after URI or viral/bacterial infection, but labyrinthitis has tinnitus and hearing loss (vestibular neuritis has neither)

 Treatment  Rest, anti-emetics, (if bacterial etiology)

Distinguishing Vertigo

VERTIGO With Without Tinnitus Without Episodic Persistent Associated Hearing Hearing Tinnitus Vertigo Vertigo With URI Loss Loss

Meniere's X X X Disease

BPPV X X X

Vestibular Neuritis X X X X

Labyrinthitis X X X X

E. Migrainous Vertigo/ Vestibular migraine

 Symptoms  Episodic vertigo with a current migraine or history of migraine and one of the following during at least two episodes of vertigo:  migraine headache  photophobia   aura

7 8/6/2014

2. Presyncope

 Feeling of losing consciousness or blacking out

 Cardiovascular causes include:  Arrhythmias  Myocardial infarction  Carotid artery stenosis  Ortho-static hypotension.

 Symptoms caused by postural changes suggest orthostatic hypotension.  Many cardiovascular increase the risk of orthostatic hypotension in older persons, including reserpine (at doses > 0.25 mg), doxazosin, and clonidine.

3. Lightheadedness

 Vague symptoms, feeling disconnected with the environment

 Psychiatric causes of lightheadedness are common 

 Depression and alcohol intoxication have also been found to overlap with dizziness.

 Hyperventilation syndrome causes lightheadedness. Patients may sigh repeatedly, have chest pain, paraesthesias, bloating, and epigastric pain.

4. Disequilibrium

 Sense of feeling off-balance

 Potential causes include:  Stroke  Poor vision  Parkinson disease   Musculoskeletal disorders  Meds: Benzodiazepines and tricyclic antidepressants increase the risk of ataxia and falls in older persons.

8 8/6/2014

Dizziness: A Diagnostic Approach ROBERT E. POST, MD, LORI M. DICKERSON, PharmD, Medical University of South Carolina, Charleston, South Carolina. Am Fam Physician. 2010 Aug 15;82(4):361-368.

Hearing Loss

Hearing loss

 Normal conversations use frequencies of 500 to 3,000 Hz at 45 - 60 dB.

 After 60 years of age, hearing declines by about 1 dB annually.

 Men usually experience greater hearing loss and earlier onset compared with women. Hearing Loss

Sensorineural Conductive

9 8/6/2014

Sensorineural vs

Sensorineural hearing Conductive hearing loss loss

 Problem converting  Usually caused by mechanical vibrations to problems in the external electrical potential in the or that and/or in interfere with transmitting auditory nerve sound and its conversion transmission to the to mechanical vibrations. brain. Usually caused by permanent damage in the .

Sensorineural Hearing Loss

 >90% of older persons with hearing loss have age-related sensorineural hearing loss  = hearing loss related to aging.  Symptoms  Gradual, high-frequency, symmetric loss of hearing, worse in noisy environments.  Pathophysiology  Degenerative changes in the hair cells, auditory neurons and cochlear nuclei. (noise trauma; meds; autoimmune d/o; mechanical trauma; Meniere disease; infection)  Treatment 

Conductive Hearing loss

 Symptoms  Gradual hearing loss (), laterality (obstruction), rapid onset (TM perforation).  Pathophysiology  Pathologic- damage to TM or ossicular chain in middle ear  Cerumen; foreign body; perforated tympanic membrane; ; Otitis media with effusion; otosclerosis; .  Otosclerosis= spongy bone replaces normal bone in otic capsule causing ankylosis/fixation of  Treatment  Tx underlying cause  Surgical  Hearing aid (otosclerosis)

10 8/6/2014

Sensorineural hearing loss

 Sudden Sensorineural Hearing Loss (SSNHL)  Otologic emergency, requiring prompt evaluation  Etiologies include vascular, thromboembolic, viral, autoimmune and  Without treatment: 1/3 lose hearing, 1/3 have partial improvement in hearing and 1/3 regain hearing  Steroids

Diagnosing Hearing Loss

Weber Test

 Tuning fork on the skull in  Tuning fork is placed at mastoid midline (both cochlae stimulated) bone, when can no longer hear sound, the tuning fork is placed  Normal exam= sound heard in front of ear. midline or equally in both .  Compares air conduction (AC)  If conductive hearing loss in 1 with bone conduction (BC) ear, the sound will be loudest in that same ear (will lateralize)  Normally AC > BC- which means that sound in front of pinna is  When unilateral sensorineural normally perceived twice as long hearing loss is present, tone is as sound placed on mastoid heard in unaffected / opposite process (AC>BC) ear  Conductive Hearing loss= AC < BC (negative Rinne) or BC= AC

 Sensorineural hearing loss= duration of both AC and BC are reduced, but 2:1 ratio remains the same (Pos Rinne)- AC > BC

Rhinosinusitis

11 8/6/2014

Rhinosinusitis

 Pathophysiology  Inflammation of the mucosa of 1 or more of the paranasal sinuses, usually occurs with rhinitis  Causes include mucosal edema, impaired local immmunity and ciliary dysfunction which impaired sinus drainage and mucous stasis. Bacterial infection.

Rhinosinusitis

 The American Academy of Otolaryngology–Head and Neck Surgery defines subtypes of rhinosinusitis based on symptom duration:  Acute, sub-acute, recurrent acute, and chronic  Acute rhinosinusitis is further categorized as bacterial or viral.

Rhinosinusitis Duration of Symptoms

Acute Up to 4 weeks Subacute At least 4 weeks, but less than 12weeks Recurrent Acute 4 or more episodes/year with remission btw episodes (each lasting 7 days at least) Chronic 12 weeks or longer (variable) Acute Rhinosinusitis in Adults. ANN M. ARING, MD, and MIRIAM M. CHAN, PharmD, Riverside Methodist Hospital, Columbus, Ohio. Am Fam Physician. 2011 May 1;83(9):1057-1063.

Acute Rhinosinusitis

 Making the Dx of Rhinosinusitis  Major vs Minor criteria  Major- facial pain and pressure, nasal congestion and obstruction, nasal discharge, discolored posterior discharge, anosmia or hyposmia, fever and purulence on intranasal exam  Minor- headache, otalgia or ear pressure, halitosis, dental pain, cough, fever (irritability in children).  Dx probable if 2 or more major factors or 1 major and 2 or more minor factors are present  Dx suggestive if 1 major factor or 2 minor factors are present

 IDSA: these diagnostic criteria do not adequately distinguish bacterial from viral infection.

According to the 1996 Task Force on Rhinosinusitis, by Amer Acad of Otolaryngology- Head and Neck Surgery, via Rakel

12 8/6/2014

Acute Rhinosinusitis

 Risk Factors  Rhinitis  Anatomic abnormalities (septal deviation, choanal atresia, foreign body, etc)  Nasal polyps  Immunodeficiency  Kartagener’s syndrome (primary ciliary dysfunction)  Smoking, nasal decongestant abuse or cocaine abuse (ciliary dysfunction)  GERD

Acute Rhinosinusitis

 Etiology  Viral  MCC of rhinosinusitis; prevalence 90-98%  MC viruses are rhinovirus, adenovirus, influenza virus, and parainfluenza virus.  In most patients improves in 7-10 days w/o treatment.  Mild symptoms < 7 days duration can be managed with supportive care: , Saline nasal irrigation, Intranasal .  Symptom persistence increases likelihood of bacterial infection

Acute Rhinosinusitis

 Etiology, cont’d  Bacterial  Prevalence is 2-10%  MCC causes are 1) Pneumococcus spp., 2) Haemophilus influenzae, 3) Moraxella catarrhalis (beta-lactamase production is common), Staph (esp in chronic).  Allergic, Fungal, etc

 June 2013, AAP released new guidelines for Sinusitis in children

13 8/6/2014

Acute Rhinosinusitis

 Complications  Periorbital  Orbital abscess  Cavernous sinus thrombosis  Meningitis  Intracranial abscess   Mucocele

Making the Diagnosis of Acute Bacterial Rhinosinusitis

 Symptoms lasting ≥ 10 days without evidence of clinical improvement (strong, low moderate)

 Onset with severe symptoms/signs of high fever [102F] and purulent nasal discharge or facial pain lasting for at least 3–4 consecutive days at the beginning of illness (strong, low-moderate)

 ‘‘Doublesickening.’’ Worsening symptoms or signs [new onset of fever, headache, or increase in nasal discharge] following a typical viral upper respiratory infection that has lasted 5–6 days and was initially improving (strong, low- moderate).

IDSA Guidelines 2012

Oral Antibiotics for ABRS (IDSA 2012 Guidelines)

 Initial Empiric Tx = Amoxicillin/Clavulanate (changed from amox alone)  Amoxicillin/Clavulanate 500 mg/125 mg q8 or 875 mg/125 mg q12  Recommended length of tx = 10 days. (3-5 day tx may be effective/have fewer adverse effects.)

14 8/6/2014

Can “High Dose Amox” be used for Initial Empiric Therapy? Yes! Amoxicillin/Clavunate 2 g po bid or 90 mg/kg/day po bid CAN be used as initial empiric therapy in the following situations:

 Adults with ABRS from areas with high endemic rates (≥10%) of invasive penicillin-nonsusceptible S. pneumoniae,  Severe infection (eg, evidence of systemic toxicity with fever of 39C [102F] or higher, and threat of suppurative complications)  Daycare attendance  Age <2 or >65 years  Recent hospitalization  use within the past month  Immunocompromised

Alternatives to Amox/Clavulanate as Empiric Therapy:

 Alternatives to Amoxicillin/Clavulanate for initial empiric therapy include (PCN , etc) :  Doxycycline 100 bid or 200 qdaily: Highly active against respiratory and with excellent pharmacokinetic/dynamic properties  [Fluoroquinolones (2nd line)]

 The following are NO LONGER recommended as alternatives to amoxicillin/clavulanate according to IDSA:  2nd / 3rd generation cephalosporins (as monotherapy) due to variable rates of resistance  Trimethoprim/sulfamethoxazole- high rates of resistance against S.pneumoniae and H. Influenza  Macrolides: Azithromycin, Clarithromycin- due to high rates of resistance among S. pneumoniae (strong, moderate)

Oral Antibiotics for ABRS

 For moderate disease, recent antibiotic use, or failed initial therapy, the following ARE recommended:

 Amoxicillin/clavulanate XR 2,000 mg/125 mg bid for 10 days  Levofloxacin 500 mg qdaily for 10 to 14 days or 750 mg qdaily for 5 days  Moxifloxacin 400 mg per day for 10 days

IDSA.

15 8/6/2014

Chronic Sinusitis

 Pearls:  Imaging is not recommended for uncomplicated sinusitis (grade b/c).  CT is the most sensitive test for detecting maxillary sinusitis

Otitis Externa

Otitis Externa

 Inflammation/infection of the external auditory canal and/or

 Pathophysiology  Glands in produce cerumen that provides protection via a antimicrobial lysozyme. Cerumen has a pH level of 6.9, which discourages microbial growth.

 Risk factors for otitis externa include:  Absence of cerumen (excessive cleaning)  Thickened cerumen fosters retention of H20 and debris  Water (macerates skin of canal and raises pH)  Trauma (cotton swab or foreign body)

16 8/6/2014

Symptoms

 Otalgia  Itching  Fullness  With or without hearing loss or jaw pain  Tenderness of the or pinna  Diffuse ear edema or erythema or both  With or without otorrhea  Regional lymphadenitis  Tympanic membrane erythema  Cellulitis of the pinna

Otitis Externa

 Causes:  (50%)  Staph aureus (23%)  Anaerobes and gram-negative organisms (12.5%)  Fungi; and Candida species (12.5%).  Others = furunculosis, seb derm, , contact

 Necrotizing "malignant" otitis externa  infection that extends into deep tissues adjacent to the auditory canal.  may cause cellulitis and osteomyelitis  RF= immunocompromised, mellitus  rarely described in children.

Otitis Externa

Topical Antibiotic Treatments

 Neomycin, polymyxin B, hydrocortisone. Neomycin sensitizing in 5 to 18 percent of patients; ototoxic potential

 Fluoroquinolone, with or without steroid. Minimally irritating and infrequently sensitizing; only agent approved if tympanic membrane is perforated

 Aminoglycoside- Usually ophthalmic preparation (e.g., gentamicin, tobramycin) but also for bacterial acute OE; minimally irritating; ototoxic potential

17 8/6/2014

Otitis Externa

Other Topical Preparations

 Steroid. For underlying dermatitis (e.g., atopic, psoriasis) if it is the cause of chronic OE; cutaneous atrophy with prolonged use

 2.0% (Vosol), with or without steroid. OE of bacterial or fungal origin in immunocompetent patients;

 2.75% or 90% to 95% isopropyl alcohol. OE of bacterial or fungal origin in immunocompetent patients, but mainly applied as prophylaxis after swimming.

 Tolnaftate (Tinactin) or clotrimazole (Lotrimin). OE of fungal origin solution easier than cream; minimally irritating

Hoarseness

Hoarseness

 Any patient with hoarseness lasting longer than two weeks in the absence of an apparent benign cause requires a thorough evaluation of the larynx by direct or indirect laryngoscopy.

 Causes of Chronic Hoarseness   GERD  Polyps  Nodules  Functional voice disorders  Neurological disorders

 Causes of Acute Hoarseness  Vocal abuse  Laryngitis  Smoking

18 8/6/2014

Hoarseness

 Important points  Cough- could indicate inflammation of vocal cords or Cancer of larynx or lung  Dysphagia/odynophagia= disorders of pharynx and esophagus  Hemoptysis with hoarseness should be considered malignancy until proven otherwise  Take note of smoking history  Visualization of the larynx by direct or indirect laryngoscopy is absolutely necessary for all patients with hoarseness that does not resolve on its own or with medical therapy.  Referral to ENT

SCC of the larynx

 Hoarseness can be a very early symptom of SCC of larynx and should never be simply attributed to “laryngitis” without proper evaluation

 Detection of cancer requires visualization of the larynx

 Indirect or direct laryngoscopy usually shows  Well-circumscribed exophytic lesion in endolarynx  most frequently on one of the true vocal cords

SCC of the larynx

 Squamous cell carcinoma of the larynx is the most common malignancy of the larynx

 Peak age= 60-65 y/o, Men > women

of larynx are MC in smokers and ETOH abusers  When both factors are present, the risk of cancer becomes 50% greater than additive risk of each  Only 2-5% of laryngeal cancer patients have no history of smoking

19 8/6/2014

Additional Slides

Vertigo: Peripheral vs. Central

Peripheral vestibular disorder Central vestibular disorder

 Originates from vestibular  Originates from nerve and cerebellum, brainstem, thalamus, cortex   Vertigo often episodic Vertigo often constant   Not associated with MAY be associated with neurology symptoms or LOC neurological symptoms or LOC

 Nystagmus is usually  Nystagmus is purely horizontal and rotational horizontal, vertical or rotational

BPPV treatment: Description of the Epley Maneuver

 Epley maneuver (canalith repositioning).  (A) The patient sits with head rotated 45 degrees to the right.  (B) Physician lays the patient into supine position with head hanging over the end of the table.  (C) The head is then rotated 90 degrees to the left  (D) Head and body are rotated together an additional 90 degrees until the patient is 135 degrees from the initial supine position.  (E) Patient is brought to a sitting position while the head remains tilted. Finally, the head is brought forward and downward to an angle of 20 degrees. The physician should pause at each position until nystagmus resolves, and repeat the series until no nystagmus is present.  A video demonstration of this maneuver is available at: http://www.youtube.com/watch?v=ZqokxZRbJfw&NR=1

Dizziness: A Diagnostic Approach ROBERT E. POST, MD, LORI M. DICKERSON, PharmD, Medical University of South Carolina, Charleston, South Carolina. Am Fam Physician. 2010 Aug 15;82(4):361-368.

20 8/6/2014

Prevention Tips for Otitis Externa

Prevention

 Who needs prevention? Immunocompromised; systemic dermatologic condition, contact sensitivities to an ototopical agent, excessive perspiration excessively; when water sports activities are common  Can use acidifying or alcohol drops during the at-risk period (e.g., swim season, scuba diving trip)  Use of a hair dryer with or without a head tilt to aid fluid clearance  Avoid of cotton swabs.  Use of hypoallergenic ear canal molds with or without tight swim caps to reduce infections is controversial.

Bibliography

 Treatment of Vertigo. RANDY SWARTZ, M.D., University of California, San Diego, School of Medicine, La Jolla. PAXTON LONGWELL, M.D., California; Corpus Christi, Texas. Am Fam Physician. 2005 Mar 15;71(6):1115-1122.

 Dizziness: A Diagnostic Approach. ROBERT E. POST, MD, LORI M. DICKERSON, PharmD, Medical University of South Carolina, Charleston, South Carolina. Am Fam Physician. 2010 Aug 15;82(4):361-368.

 Initial Evaluation of Vertigo. RONALD H. LABUGUEN, M.D., University of Southern California, Los Angeles, California. Am Fam Physician. 2006 Jan 15;73(2):244-251..

 Hearing Loss in Older Adults. ANNE D. WALLING, MB, ChB, and GRETCHEN M. DICKSON, MD, MBA. University of Kansas School of Medicine—Wichita, Wichita, Kansas. Am Fam Physician. 2012 Jun 15;85(12):1150- 1156.

 Acute Rhinosinusitis in Adults. ANN M. ARING, MD, and MIRIAM M. CHAN, PharmD, Riverside Methodist Hospital, Columbus, Ohio. Am Fam Physician. 2011 May 1;83(9):1057-1063

 Otitis Externa: Review and Clinical UpdateJ. DAVID OSGUTHORPE, M.D., Medical University of South Carolina, Charleston, South Carolina. DAVID R. NIELSEN, M.D., American Academy of Otolaryngology–Head and Neck Surgery, Alexandria, Virginia. Am Fam Physician. 2006 Nov 1;74(9):1510-1516.

 Otitis Externa. Medscape. Joseph P Garry, MD, FACSM, FAAFP Associate Professor, Sports Medicine Faculty, Department of Family and Community Medicine, University of Minnesota Medical School

 Hoarseness in Adults. RAYMOND H. FEIERABEND, MD, and SHAHRAM N. MALIK, MD, Department of Family Medicine, East Tennessee State University, Bristol, Tennessee. Am Fam Physician. 2009 Aug 15;80(4):363-370. th  Textbook for Family Medicine, 8 edition. Robert E. Rakel and David P. Rakel. Elselvier Saunders, 2011

 Vestibular neuritis. JOSEPH B. NADOL, JR., MD, OTOLARYNGOL HEAD NECK SURG 1995; I 12:162-72.

 IDSA Guidelines: IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. 2012

 Dynamed

 Essential Evidence Plus

21